Abstract:Objective: This study aims to comprehensively analyze alternative splicing (AS) features in colorectal cancer (CRC) using integrative multi-omics and to elucidate their relationship with the CRC immune microenvironment. Methods: Transcriptomic data, clinical information, and Percent Spliced In (PSI) values of AS events for CRC patients were obtained from The Cancer Genome Atlas (TCGA) and TCGA SpliceSeq databases. Differentially expressed AS events were identified. Univariate Cox analysis was used to pinpoint prognosis-related AS events. A prognostic risk model was developed and validated using multivariate Cox analysis, patient survival analysis, and the area under the receiver operating characteristic (ROC) curve (AUC). Gene Set Enrichment Analysis (GSEA), immune infiltration, immunotherapy, chemotherapy sensitivity analyses, and regulatory relationships between AS events and splicing factors (SFs) were conducted. Single-cell sequencing was used to study the distribution of key factors. siRNA and overexpression vectors were utilized to silence/overexpress BCAS1 in CRC cells and evaluate their effects on cell growth, migration, and invasion. Furthermore, the interaction between BCAS1 and ANO7 pre-mRNA was investigated using RIP-PCR. Results: 82 prognosis-related AS events were identified in CRC patients. A 15-AS prognostic model was constructed, which correlated with immune cell infiltration and showed differences in immunotherapy and chemotherapy sensitivity. BCAS1 was identified as a potential regulator of the ANO7|58341|AT splicing event in CRC. Single-cell sequencing analysis revealed the distribution of BCAS1 and ANO7 in cancer stem cells. In vitro experiments demonstrated that overexpression of BCAS1 and silencing of ANO7 inhibit the proliferation, migration, and invasion of CRC cells. Moreover, BCAS1 suppresses the progression of CRC by modulating ANO7 alternative splicing. Conclusion: This study provides new insights into the role of alternative splicing in colorectal cancer, particularly the potential regulatory action of BCAS1 on the ANO7|58341|AT splicing event. It also identifies the impact of alternative splicing on the tumor microenvironment and potential implications for immunotherapy, highlighting its relevance for the in-depth study and treatment of CRC.

Uxt-As1-Induced Alternative Splicing of Uxt is Associated with Tumor Progression in Colorectal Cancer

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

SRSF6-regulated Alternative Splicing That Promotes Tumour Progression Offers a Therapy Target for Colorectal Cancer

GLTSCR1 Coordinates Alternative Splicing and Transcription Elongation of ZO1 to Regulate Colorectal Cancer Progression.

SP1-induced PROX1-AS1 contributes to tumor progression by regulating miR-326/FBXL20 axis in colorectal cancer

Systematic profiling of alternative splicing of ZNF family in Colorectal cancer

UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy

The role of XBP-1-mediated unfolded protein response in colorectal cancer progression-a regulatory mechanism associated with lncRNA-miRNA-mRNA network

Long Non-Coding RNA HOXD-AS1 Promotes Tumor Progression and Predicts Poor Prognosis in Colorectal Cancer

Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response

Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.

APEX1 regulates alternative splicing of key tumorigenesis genes in non-small-cell lung cancer

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer

Long Noncoding RNA XIST Expedites Metastasis and Modulates Epithelial–mesenchymal Transition in Colorectal Cancer

Deciphering Alternative Splicing Events and Their Therapeutic Implications in Colorectal Cancer

Elevated Expression of ASXL2 is Associated with Poor Prognosis in Colorectal Cancer by Enhancing Tumorigenesis and Inducing Cell Proliferation

Long non-coding RNAs are involved in alternative splicing and promote cancer progression

ASXL2 promotes colorectal cancer tumorigenesis by inducing cell proliferation

HOXD9 transcriptionally induced UXT facilitate breast cancer progression via epigenetic modification of RND3

BCLAF1 and Its Splicing Regulator SRSF10 Regulate the Tumorigenic Potential of Colon Cancer Cells

CUL4B-DDB1-COP1-mediated UTX Downregulation Promotes Colorectal Cancer Progression.